Endothelial genetic deletion of CD147 induces changes in the dual function of the blood-brain barrier and is implicated in Alzheimer's disease.
Hao WangJian-Jun LvYu ZhaoHao-Lin WeiTian-Jiao ZhangHai-Jiao YangZhi-Nan ChenJian-Li JiangPublished in: CNS neuroscience & therapeutics (2021)
Our findings suggested that targeting CD147 in BECs may represent a novel therapeutic strategy, which promoted the design of future experimental investigations and the mechanistic understanding of neurodegenerative diseases.